Dianthus Therapeutics, Inc. DNTH
Nov 12, 2026, 1:36 PM EST
- YTD
- +117.59%
- 1 year
- +131.59%
DNTH free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-129,273,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -129,273,000 | -50,988,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -78,285,000 | -41,314,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -36,971,000 | -7,762,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -29,209,000 | 31,586,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -60,795,000 | 3,628,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -64,423,000 | -4,260,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -60,163,000 | -10,617,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -49,546,000 | -25,084,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -24,462,000 | -17,794,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -6,668,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:18.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.